$IQV News

IQV Stock Gains 42% in 3 Months: Here's What You Should Know

How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook

IQVIA, Medera Partner to Accelerate Development of Cardiac Gene Therapies

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

Is IQVIA Stock a Buy as Growth Improves but High Leverage Persists?

Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last

The Backlog Tells the Real Story: Inside IQVIA’s Blowout Q2

IQVIA Holdings (IQV) Price Target Increased by 19.30% to 277.88

An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know

An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know

An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

IQVIA (IQV) Stock Sees Modest Fair Value Lift After Mixed Analyst Target Changes

JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $285

Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $276

TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $288

RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $247

IQVIA: A Great Business At The Wrong Price (Rating Downgrade)

BMO Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $270

IQVIA Holdings (IQV) Earnings Beat Keeps Fair Value In Focus

Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $287